Mackaness James H's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Mar 31, 2025
- Accession no.
- 0001415889-25-009295
- Filed
- Mar 31, 2025
- Trade date
- Mar 27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 16 non-derivative transactions and 5 derivative transactions. Open-market sales total $6.29M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mackaness James HCIK 0001422484 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Common Stock | SSaleDisposed | −1,669 | $65.97 | −$110,103.93 | 124,129 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −2,717 | $66.79 | −$181,468.43 | 121,412 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −4,940 | $67.70 | −$334,438 | 116,472 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −6,498 | $68.79 | −$446,997.42 | 109,974 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −3,762 | $69.84 | −$262,738.08 | 106,212 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −387 | $70.73 | −$27,372.51 | 105,825 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −563 | $71.74 | −$40,389.62 | 105,262 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −86 | $72.64 | −$6,247.04 | 105,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $30.75 | +$615,000 | 125,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $5.10 | +$51,000 | 135,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +5,000 | $2.60 | +$13,000 | 140,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $2.41 | +$36,150 | 155,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $5.25 | +$105,000 | 175,176 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −25,799 | $69.07 | −$1,781,936.93 | 149,377 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −36,157 | $70.03 | −$2,532,074.71 | 113,220 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −8,044 | $70.80 | −$569,515.2 | 105,176 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 3,000 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 15,000 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 67,251 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.